Nonsurgical treatment of male infertility: Specific and empiric therapy

Biologics: Targets and Therapy

Volumn 1, Issue 3, 2007, Pages 259-269

  Cocuzza, Marcello ^a   Agarwal, Ashok ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Drug therapy; Male infertility; Oligospermia

Indexed keywords

EID: 49149110980     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Abel BJ, Carswell G, Elton R, et al. 1982. Randomised trial of clomiphene citrate treatment and vitamin C for male infertility. Br J Urol, 54:780-4.
2. Agarwal A, Nallella KP, Allamaneni SS, et al. 2004. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online, 8:616-27.
3. Agarwal A, Prabakaran SA. 2005. Mechanism, measurement, and prevention of oxidative stress in male reproductive physiology. Indian J Exp Biol, 43:963-74.
4. Agarwal A, Prabakaran SA, Said TM. 2005. Prevention of oxidative stress injury to sperm. J Androl, 26:654-60.
5. Agarwal A, Said TM. 2004. Carnitines and male infertility. Reprod Biomed Online, 8:376-84.
6. Agarwal A, Sharma RK, Nallella KP, et al. 2006. Reactive oxygen species as an independent marker of male factor infertility. Fertil Steril, 86:878-85.
7. AinMelk Y, Belisle S, Carmel M, et al. 1987. Tamoxifen citrate therapy in male infertility. Fertil Steril, 48:113-17.
8. Aitken RJ, Buckingham D, West K, et al. 1992. Differential contribution of leucocytes and spermatozoa to the generation of reactive oxygen species in the ejaculates of oligozoospermic patients and fertile donors. J Reprod Fertil, 94:451-62.
9. Aitken RJ, West K, Buckingham D. 1994. Leukocytic infiltration into the human ejaculate and its association with semen quality, oxidative stress, and sperm function. J Androl, 15:343-52.
10. Allag IS, Alexander NJ. 1979. Clomiphene citrate therapy for male infertility. Urology, 14:500-3.
11. Arap MA, Vicentini FC, Cocuzza M, et al. 2007. Late hormonal levels, semen parameters and presence of antisperm antibodies in patients treated for testicular torsion. J Androl.
12. Athayde KS, Cocuzza M, Agarwal A, et al. 2007. Development of normal reference values for seminal reactive oxygen species and their correlation with leukocytes and semen parameters in a fertile population. J Androl.
13. Badenoch DF, Waxman J, Boorman L, et al. 1988. Administration of a gonadotropin releasing hormone analogue in oligozoospermic infertile males. Acta Endocrinol Copenh, 117:265-7.
14. Barkay J, Harpaz-Kerpel S, Ben-Ezra S, et al. 1984. The prostaglandin inhibitor effect of antiinflammatory drugs in the therapy of male infertility. Fertil Steril, 42:406-11.
15. Bartsch G, Scheiber K. 1981. Tamoxifen treatment in oligozoospermia. Eur Urol, 7:283-7.
16. Berger RE, Karp LE, Williamson RA, et al. 1982. The relationship of pyospermia and seminal fluid bacteriology to sperm function as reflected in the sperm penetration assay. Fertil Steril, 37:557-64.
17. Broderick GA, Tom R, McClure RD. 1989. Immunological status of patients before and after vasovasostomy as determined by the immunobead antisperm antibody test. J Urol, 142:752-5.
18. Buettner GR. 1993. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys, 300:535-43.
19. Burris AS, Clark RV, Vantman DJ, et al. 1988. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertil Steril, 50:343-7.
20. Burrows PJ, Schrepferman CG, Lipshultz LI. 2002. Comprehensive office evaluation in the new millennium. Urol Clin North Am, 29:873-94.
21. Buvat J, Ardaens K, Lemaire A, et al. 1983. Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen. Fertil Steril, 39:700-3.
22. Check JH, Chase JS, Nowroozi K, et al. 1989. Empirical therapy of the male with clomiphene in couples with unexplained infertility. Int J Fertil, 34:120-2.
23. Check ML, Check JH, Katsoff D, et al. 2000. ICSI as an effective therapy for male factor with antisperm antibodies. Arch Androl, 45:125-30.
24. Chuang AT, Howards SS. 1998. Male infertility. Evaluation and nonsurgical therapy. Urol Clin North Am, 25:703-13.
25. Ciaccio LA, Joseph AA, Kincl FA. 1978. Direct inhibition of testicular function in rats by estriol and progesterone. J Steroid Biochem, 9:1257-9.
26. Clarke GN, Bourne H, Baker HW. 1997. Intracytoplasmic sperm injection for treating infertility associated with sperm autoimmunity. Fertil Steril, 68:112-17.
27. Comhaire FH, Christophe AB, Zalata AA, et al. 2000. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fatty Acids, 63:159-65.
28. Comhaire FH, Rowe PJ, Farley TM. 1986. The effect of doxycycline in infertile couples with male accessory gland infection: a double blind prospective study. Int J Androl, 9:91-8.
29. Conte D, Romanelli F, Isidori A. 1990. [Treatment of male idiopathic sterility with gonadotropin]. Minerva Endocrinol, 15:91-4.
30. Costa M, Canale D, Filicori M, et al. 1994. L-carnitine in idiopathic asthenozoospermia: a multicenter study Italian Study Group on Carnitine and Male Infertility. Andrologia, 26:155-9.
31. Crich JP, Jequier AM. 1978. Infertility in men with retrograde ejaculation: the action of urine on sperm motility, and a simple method for achieving antegrade ejaculation. Fertil Steril, 30:572-6.
32. Crottaz B, Senn A, Reymond MJ, et al. 1992. Follicle-stimulating hormone bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: double-blind trial with gonadotropin-releasing hormone. Fertil Steril, 57:1034-43.
33. Crowley WF Jr, Filicori M, Spratt DI, et al. 1985. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res, 41:473-531.
34. Crowley WF, Whitcomb RW. 1990. Gonadotropin-releasing hormone deficiency in men: diagnosis and treatment with exogenous gonadotropinreleasing hormone. Am J Obstet Gynecol, 163:1752-8.
35. Cunningham GR, Lipshultz LI. 1986. Diseases of the testes and male sex organs. In: Kohler PO ed. Basic clinical endocrinology. New York: John Wiley and Sons, 263-78.
36. De Almeida M, Soufir JC. 1977. Corticosteroid therapy for male autoimmune infertility. Lancet, 2:815-16.
37. de Lamirande E, Gagnon C. 1995. Impact of reactive oxygen species on spermatozoa: a balancing act between beneficial and detrimental effects. Hum Reprod, 10 (Suppl 1):15-21.
38. Debruyne FM. 2000. Alpha blockers: are all created equal? Urology, 56:20-2.
39. Dollar JR, Blackwell RE. 1986. Diagnosis and management of prolactinomas. Cancer Metastasis Rev, 5:125-38.
40. Dondero F, Lenzi A, Gandini L, et al. 1993. Immunological infertility in humans. Exp Clin Immunogenet, 10:65-72.
41. Eggert-Kruse W, Schwalbach B, Gerhard I, et al. 1991. Influence of serum prolactin on semen characteristics and sperm function. Int J Fertil, 36:243-51.
42. el-Demiry MI, Young H, Elton RA, et al. 1986. Leucocytes in the ejaculate from fertile and infertile men. Br J Urol, 58:715-20.
43. Foss GL, Tindall VR, Birkett JP. 1973. The treatment of subfertile men with clomiphene citrate. J Reprod Fertil, 32:167-70.
44. Gilbaugh JH 3rd, Lipshultz LI. 1994. Nonsurgical treatment of male infertility. An update. Urol Clin North Am, 21:531-48.
45. Glezerman M, Lunenfeld E, Potashnik G, et al. 1993. Efficacy of kallikrein in the treatment of oligozoospermia and asthenozoospermia: a double blind trial. Fertil Steril, 60:1052-6.
46. Greenberg SH, Lipshultz LI, Wein AJ. 1978. Experience with 425 subfertile male patients. J Urol, 119:507-10.
47. Haas GG Jr. 1986. The inhibitory effect of sperm-associated immunoglobulins on cervical mucus penetration. Fertil Steril, 46:334-7.
48. Haidl G. 2002. Management strategies for male factor infertility. Drugs, 62:1741-53.
49. Haidl G, Schill WB. 1991. Guidelines for drug treatment of male infertility. Drugs, 41:60-8.
50. Halliwell B. 1990. How to characterize a biological antioxidant. Free Radic Res Commun, 9:1-32.
51. Heller CG, Rowley MJ, Heller GV. 1969. Clomiphene citrate: a correlation of its effect on sperm concentration and morphology, total gonadotropins, ICSH, estrogen and testosterone excretion, and testicular cytology in normal men. J Clin Endocrinol Metab, 29:638-49.
52. Hendry WF. 1998. Disorders of ejaculation: congenital, acquired and functional. Br J Urol, 82:331-41.
53. Hendry WF, Hughes L, Scammell G, et al. 1990. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet, 335:85-8.
54. Hendry WF, Treehuba K, Hughes L, et al. 1986. Cyclic prednisolone therapy for male infertility associated with autoantibodies to spermatozoa. Fertil Steril, 45:249-54.
55. Henkel R, Kierspel E, Stalf T, et al. 2005. Effect of reactive oxygen species produced by spermatozoa and leukocytes on sperm functions in nonleukocytospermic patients. Fertil Steril, 83:635-42.
56. Henkel R, Maass G, Hajimohammad M, et al. 2003. Urogenital inflammation: changes of leucocytes and ROS. Andrologia, 35:309-13.
57. Inkster S, Yue W, Brodie A. 1995. Human testicular aromatase: immunocytochemical and biochemical studies. J Clin Endocrinol Metab, 80:1941-7.
58. Irshad M, Chaudhuri PS. 2002. Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol, 40:1233-9.
59. Jane JA Jr, Laws ER Jr. 2001. The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg, 193:651-9.
60. Jennings MG, McGowan MP, Baker HW. 1986. Is conventional bacteriology useful in the management of male infertility? Clin Reprod Fertil, 4:359-66.
61. Kamischke A, Behre HM, Bergmann M, et al. 1998. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod, 13:596-603.
62. Kamischke A, Nieschlag E. 1999. Analysis of medical treatment of male infertility. Hum Reprod, 14 (Suppl 1):1-23.
63. Kessopoulou E, Powers HJ, Sharma KK, et al. 1995. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril, 64:825-31.
64. Klingmuller D, Schweikert HU. 1985. Maintenance of spermatogenesis by intranasal administration of gonadotropin-releasing hormone in patients with hypothalamic hypogonadism. J Clin Endocrinol Metab, 61:868-72.
65. Knuth UA, Honigl W, Bals-Pratsch M, et al. 1987. Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. J Clin Endocrinol Metab, 65:1081-7.
66. Kodama H, Yamaguchi R, Fukuda J, et al. 1997. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril, 68:519-24.
67. Koide SS, Wang L, Kamada M. 2000. Antisperm antibodies associated with infertility: properties and encoding genes of target antigens. Proc Soc Exp Biol Med, 224:123-32.
68. Krause W, Holland-Moritz H, Schramm P. 1992. Treatment of idiopathic oligozoospermia with tamoxifen a randomized controlled study. Int J Androl, 15:14-18.
69. Kulin HE, Reiter EO. 1972. Gonadotropin suppression by low dose estrogen in men: evidence for differential effects upon FSH and LH. J Clin Endocrinol Metab, 35:836-9.
70. Lenzi A, Culasso F, Gandini L, et al. 1993. Placebo-controlled, doubleblind, cross-over trial of glutathione therapy in male infertility. Hum Reprod, 8:1657-62.
71. Lenzi A, Lombardo F, Sgro P, et al. 2003. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril, 79:292-300.
72. Lenzi A, Picardo M, Gandini L, et al. 1994. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod, 9:2044-50.
73. Lenzi A, Sgro P, Salacone P, et al. 2004. A placebo-controlled doubleblind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril, 81:1578-84.
74. Lewis SE, Boyle PM, McKinney KA, et al. 1995. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril, 64:868-70.
75. Liu PY, Handelsman DJ. 2003. The present and future state of hormonal treatment for male infertility. Hum Reprod Update, 9:9-23.
76. Mancini A, Guitelman A, Levalle O, et al. 1984. Bromocriptine in the management of infertile men after surgery of prolactin secreting adenomas. J Androl, 5:294-6.
77. March MR, Isidori A. 2002. New frontiers in the treatment of male sterility. Contraception, 65:279-81.
78. Marshburn PB, Kutteh WH. 1994. The role of antisperm antibodies in infertility. Fertil Steril, 61:799-811.
79. Maruyama DK Jr, Hale RW, Rogers BJ. 1985. Effects of white blood cells on the in vitro penetration of zona-free hamster eggs by human spermatozoa. J Androl, 6:127-35.
80. Matorras R, Perez C, Corcostegui B, et al. 1997. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum Reprod, 12:24-8.
81. Molitch ME. 1999. Medical treatment of prolactinomas. Endocrinol Metab Clin North Am, 28:143-69, vii.
82. Mortimer CH, McNeilly AS, Fisher RA, et al. 1974. Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunction. Br Med J, 4:617-21.
83. Ochsendorf FR. 1999. Infections in the male genital tract and reactive oxygen species. Hum Reprod Update, 5:399-420.
84. Okada H, Tatsumi N, Kanzaki M, et al. 1997. Formation of reactive oxygen species by spermatozoa from asthenospermic patients: response to treatment with pentoxifylline. J Urol, 157:2140-6.
85. Omu AE, al-Qattan F, Abdul Hamada B. 1996. Effect of low dose continuous corticosteroid therapy in men with antisperm antibodies on spermatozoal quality and conception rate. Eur J Obstet Gynecol Reprod Biol, 69:129-34.
86. Padron OF, Brackett NL, Sharma RK, et al. 1997. Seminal reactive oxygen species and sperm motility and morphology in men with spinal cord injury. Fertil Steril, 67:1115-20.
87. Pasqualotto FF, Sharma RK, Kobayashi H, et al. 2001. Oxidative stress in normospermic men undergoing infertility evaluation. J Androl, 22:316-22.
88. Paulson DF. 1979. Cortisone acetate versus clomiphene citrate in per-germinal idiopathic oligospermia. J Urol, 121:432-4.
89. Pavlovich CP, King P, Goldstein M, et al. 2001. Evidence of a treatable endocrinopathy in infertile men. J Urol, 165:837-41.
90. Raman JD, Schlegel PN. 2002. Aromatase inhibitors for male infertility. J Urol, 167:624-9.
91. Rolf C, Cooper TG, Yeung CH, et al. 1999. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod, 14:1028-33.
92. Ronnberg L. 1980. The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double-blind cross-over study. Int J Androl, 3:479-86.
93. Rumke P, Hellinga G. 1959. Autoantibodies against spermatozoa in sterile men. Am J Clin Pathol, 32:357-63.
94. Schuster TG, Ohl DA. 2002. Diagnosis and treatment of ejaculatory dysfunction. Urol Clin North Am, 29:939-48.
95. Shangold GA, Cantor B, Schreiber JR. 1990. Treatment of infertility due to retrograde ejaculation: a simple, cost-effective method. Fertil Steril, 54:175-7.
96. Sharma RK, Pasqualotto AE, Nelson DR, et al. 2001. Relationship between seminal white blood cell counts and oxidative stress in men treated at an infertility clinic. J Androl, 22:575-83.
97. Shekarriz M, Sharma RK, Thomas AJ Jr, et al. 1995. Positive myeloperoxidase staining (Endtz test) as an indicator of excessive reactive oxygen species formation in semen. J Assist Reprod Genet, 12:70-4.
98. Shin D, Honig SC. 2002. Economics of treatments for male infertility. Urol Clin North Am, 29:841-53.
99. Shin D, Palermo GD, Goldstein M, et al. 1998. Indications for corticosteroids prior to epididymal sperm retrieval. Int J Fertil Womens Med, 43:165-70.
100. Shulman JF, Shulman S. 1982. Methylprednisolone treatment of immunologic infertility in male. Fertil Steril, 38:591-9.
101. Siddiq FM, Sigman M. 2002. A new look at the medical management of infertility. Urol Clin North Am, 29:949-63.
102. Sies H. 1993. Strategies of antioxidant defense. Eur J Biochem, 215:213-19.
103. Sokol RZ, Steiner BS, Bustillo M, et al. 1988. A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil Steril, 49:865-70.
104. Soufir JC, Ducot B, Marson J, et al. 1984. Levels of seminal free L(-) carnitine in fertile and infertile men. Int J Androl, 7:188-97.
105. Suleiman SA, Ali ME, Zaki ZM, et al. 1996. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl, 17:530-7.
106. Suominen JJ, Kilkku PP, Taina EJ, et al. 1991. Successful treatment of infertility due to retrograde ejaculation by instillation of serum-containing medium into the bladder A case report. Int J Androl, 14:87-90.
107. Vandekerckhove P, Lilford R, Vail A, et al. 2000. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev, CD000151.
108. Veldhuis JD, Sowers JR, Rogol AD, et al. 1985. Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. Evidence for dual defects in the gonadal axis. N Engl J Med, 312:1371-5.
109. Verhelst J, Abs R, Maiter D, et al. 1999. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab, 84:2518-22.
110. Vermeulen A, Comhaire F. 1978. Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men. Fertil Steril, 29:320-7.
111. Vicari E, Calogero AE. 2001. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod, 16:2338-42.
112. Vicari E, La Vignera S, Calogero AE. 2002. Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds. Fertil Steril, 78:1203-8.
113. Vitali G, Parente R, Melotti C. 1995. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res, 21:157-9.
114. Wang C, Chan CW, Wong KK, et al. 1983. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril, 40:358-65.
115. Wang C, Lam KS, Ma JT, et al. 1987. Long-term treatment of hyperprolactinaemia with bromocriptine: effect of drug withdrawal. Clin Endocrinol (Oxf), 27:363-71.
116. Weidner W. 1999. Which efforts towards conservative treatment of male infertility will be successful? Antibiotic therapy. Andrologia, 31:297.
117. Weidner W, Krause W, Ludwig M. 1999. Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum Reprod Update, 5:421-32.
118. [WHO] World Health Organization. 1992. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility World Health Organization. Int J Androl, 15:299-307.
119. [WHO] World Health Organization. 1999. WHO Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. New York: Cambridge University Press.
120. Willis KJ, London DR, Bevis MA, et al. 1977. Hormonal effects of tamoxifen in oligospermic men. J Endocrinol, 73:171-8.
121. Wolff H. 1995. The biologic significance of white blood cells in semen. Fertil Steril, 63:1143-57.
122. Wolff H, Anderson DJ. 1988. Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil Steril, 49:497-504.
123. Wolff H, Politch JA, Martinez A, et al. 1990. Leukocytospermia is associated with poor semen quality. Fertil Steril, 53:528-36.
124. Yanushpolsky EH, Politch JA, Hill JA, et al. 1995. Antibiotic therapy and leukocytospermia: a prospective, randomized, controlled study. Fertil Steril, 63:142-7.